Data collection
An Institutional Review Board approval was granted to retrospectively review 32 years of experience at our facility spanning from 1987 through 2019. Various techniques were required to identify cases over the years due to changes in coding and availability of the medical record prior to the introduction of digital PACS. The patients ranged from 17 years old to 95 years old (76 females, 176 males).
Cases from 1987 through 1993 and between 2001 and 2002 were not available on digital or physical record in the hospital, so the previous departmental publication from 1994 introducing fluoroscopy-guided esophageal disimpaction was referenced and yielded 48 cases [1, 2].
Cases from 1993 through 1997 were not available on digital or physical record and were not previously published; therefore, these cases were not available for review.
Cases from 1997 through 2001 were identified through the radiology department PACs exam code (BAS), yielding 3 cases.
Cases from 2002 to 2013 were identified by tracking the radiology department’s use of glucagon, which is one of the agents used in this procedure, and yielded 110 cases for review (Shortsleeve, unpublished data).
Cases from 2013 through 2019 were identified through the radiology department PACS by searching for the appropriate exam code (IMG742), yielding 91 cases from 2013 to 2019.
Indications/contraindications
Fluoroscopy-guided disimpaction is indicated in patients with acute food impaction in the distal two-thirds of the esophagus.
Contraindications for intervention can be categorized by parameters elicited through clinical history and by parameters demonstrated on the initial fluoroscopic examination, as illustrated in Table 1. Contraindications include impaction with a sharp foreign body (e.g., plastic eating utensils and bones, which increase perforation risk) and symptoms for over 24 hours (as beyond this time period, it is more likely that the food impaction has eroded the mucosa of the esophagus, predisposing the patient to increased perforation risk). History of esophageal manipulation, including esophageal dilation or esophagogastroduodenoscopy (EGD) within the past 7 days, is also a contraindication to this intervention, as these manipulations predispose the esophagus to perforation.
Table 1 Contraindications for intervention Contraindications to glucagon such as anaphylaxis to glucagon or the diagnosis of pheochromocytoma or insulinoma also preclude fluoroscopic intervention. Glucagon is contraindicated in the setting of pheochromocytoma because glucagon stimulates catecholamine release, increasing the risk of inducing a sudden state of marked hypertension. In a patient with an insulinoma, glucagon is contraindicated due to the risk of inducing rebound hypoglycemia. Although the diagnosis of diabetes mellitus is not a contraindication to combination therapy, the care team should be aware of glucagon’s theoretical risk of inducing hyperglycemia.
Specific anatomic features of the esophagus can also be a contraindication for fluoroscopic intervention. For example, the presence of esophageal stricture, benign, or malignant, is a contraindication for intervention. While treating a patient with a stricture would not harm the patient, these cases often fail because the stricture cannot relax with glucagon or distend with the effervescent agent. As a community teaching hospital, we commonly have seen our patients in the past and have access to their medical records; rather than intervention in these scenarios of a known stricture, we refer directly to the appropriate specialist.
A prominent cricopharyngeus muscle or an esophageal diverticulum, either noted on prior studies or evident upon the initial fluoroscopic evaluation, is also a contraindication for combination therapy. In these contexts, the prominent muscle would obstruct the upward release of the ingested carbon dioxide gas. It is specifically clarified that, as a Schatzki ring is not an esophageal stricture, it is thus not a contraindication for intervention; the presence of a Schatzki ring is a common feature of our candidate population, and this sub-population tends to respond well to the combination therapy.
The procedure
The radiologist must follow the standard radiation safety protocol of wearing protective eyewear and a lead apron.
The three defining mechanisms of combination therapy are demonstrated in Fig. 2. Steps 1 through 5 describe the technique of the esophageal disimpaction procedure and are illustrated in Fig. 3.
-
Step 1
Evaluate for esophageal food impaction:
-
1)
Place the patient in the standing left posterior oblique position (LPO).
-
2)
Give the patient 10–15 cc of iso-osmolar, water-soluble contrast. See Fig. 4, image A for components 1 and 2 of this step.
-
3)
Instruct the patient to drink the 10–15 cc of iso-osmolar water-soluble contrast.
-
4)
Observe the contrast bolus passing down the esophagus.
-
Step 2
If there is a mid or distal esophageal impaction identified and the patient does not have any contraindications to fluoroscopically guided intervention, then glucagon can be administered.
-
1)
Turn the fluoroscopic table to the horizontal position (patient should be supine).
-
2)
Over a period of 1 minute, administer 1 mg IV glucagon. This gradual rate of injection, as opposed to a faster rate, is performed to decrease the risk of inducing vomiting.
-
Step 3
After waiting for 5 minutes for the glucagon to relax the esophageal smooth muscle, re-position the patient into the standing position next to the fluoroscope with a trash can between the patient and radiologist in case of emesis.
-
Step 4
Add 1 packet of the effervescent agent to 30 ml of water and drink.
-
Step 5
Promptly drink 1 cup of water. Steps 4 and 5 must be completed within 30 seconds of each other to obtain maximal distention of the relaxed esophageal smooth muscle.
The LPO position optimizes the evaluation of the esophagus, as it is offset from the spine in this projection.
There are two critical features of the contrast used in this procedure. First, the contrast must be iso-osmolar; in this scenario, if the patient aspirates the contrast, pulmonary edema is avoided. Second, the contrast must be water soluble. If the patient has an esophageal perforation, water-soluble contrast, rather than barium, would leak into the mediastinum; thus, this avoids the risk of barium-associated mediastinitis if there is a perforation. Additionally, if endoscopic gastroduodenoscopy (EGD) is subsequently performed, the gastroenterologist will be able to see through the transparent, water-soluble contrast from the fluoroscopic exam.
Observing the contrast bolus passing down the esophagus demonstrates the presence or absence of impaction and the level of obstruction. Impactions below the level of the aortic arch involve the smooth musculature of the mid and distal esophagus, which will relax with glucagon.
The effervescent agent functions to distend the relaxed esophagus, and the prompt drinking of water increases the hydrostatic pressure above the food bolus; the combined effect is usually able to relieve an acute esophageal food impaction.
A unique patient scenario: the diagnostic-only exam
Our department has encountered many patients that present with a suspected esophageal impaction but are not candidates for therapeutic intervention by fluoroscopy due to at least one contraindication. The most common scenario is that of a patient who has experienced obstructive symptoms for greater than 24 hours.
In this scenario, the protocol should be tailored to prioritize patient safety and still provide valuable diagnostic information to our referring clinicians. The procedure must be abridged, stopping after step 1; with this shortened protocol, the fundamental questions of “is there an obstruction” and “at what level is the obstruction” can be answered. This diagnostic-only exam can guide the management plan for the patient, including possible ENT versus GI consultation.
Immediate post procedure evaluation
After the full combination therapy protocol is completed, an immediate post-intervention fluoroscopic image is obtained. The immediate study is performed with water-soluble contrast and answers two critical questions: did the impacted food pass and is there an esophageal leak? After both successful and unsuccessful cases, 20 cc of iso-osmolar, water-soluble contrast per swallow is given to the patient for this assessment. In cases of a successful disimpaction, two to three swallows are observed, while in an unsuccessful case, only one swallow is observed for this post-procedure evaluation. The immediate post intervention evaluation is demonstrated in Fig. 4.